#387 - AMA #83: Peptides—evaluating the science, safety, and hype in a rapidly growing field
View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this "Ask Me Anything" (AMA) episode, Peter explores the topic of gray-market peptides, one of the most requested and most confusing topics he's covered on The Drive. Peptides sit at…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from The Peter Attia Drive
See all episodes →
50%#403 ‒ Peptides: separating scientific promise from marketing hype
44%#406 ‒ Migraine, cluster headache, and tension headache: symptoms, causes, prevention, and treatment | Brian Grosberg, M.D.
43%Blood pressure: how to measure, manage, and treat high blood pressure (AMA #48 rebroadcast)
Similar episodes from other shows
More like The Peter Attia Drive →
Benefits & Risks of Peptide Therapeutics for Physical & Mental Health
Office Hours: Peptides 101: The Truth About GLP-1, Recovery, and Anti-Aging
125. Peptides Are Not a Shortcut: Here’s What Your Body Needs First with Nathalie Niddam
Episode 573: Dr. Jonathan Schoeff: Peptides and the Marketing Behind Modern Longevity - Part 1
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.